Thromb Haemost 1979; 42(05): 1523-1528
DOI: 10.1055/s-0038-1657054
Original Article
Schattauer GmbH Stuttgart

Acquired von Willebrand’s Syndrome during Autoimmune Disorder

Javier Pizzuto
The Haematology Department and from Rheumatology Department of the General Hospital, National Medical Center, Mexico City, Mexico
,
Raul Ambriz
The Haematology Department and from Rheumatology Department of the General Hospital, National Medical Center, Mexico City, Mexico
,
Maria de la Paz Reyna
The Haematology Department and from Rheumatology Department of the General Hospital, National Medical Center, Mexico City, Mexico
,
Luis M Monrroy
The Haematology Department and from Rheumatology Department of the General Hospital, National Medical Center, Mexico City, Mexico
,
Manuel R Morales
The Haematology Department and from Rheumatology Department of the General Hospital, National Medical Center, Mexico City, Mexico
,
Agustin Aviles
The Haematology Department and from Rheumatology Department of the General Hospital, National Medical Center, Mexico City, Mexico
,
Guillermo Conte
The Haematology Department and from Rheumatology Department of the General Hospital, National Medical Center, Mexico City, Mexico
,
Ruben Enriquez
The Haematology Department and from Rheumatology Department of the General Hospital, National Medical Center, Mexico City, Mexico
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Received 03. Juli 1979

Accepted 10. Juli 1979

Publikationsdatum:
23. August 2018 (online)

Preview

Summary

A case with evidence of acquired von Willebrand’s syndrome associated with systemic lupus erythmatosus and Sjögren’s syndrome is described. The patient, who had no family history of bleeding, presented a haemorrhagic diathesis of recent origin, the bleeding time was prolonged, procoagulant Factor-VIII and von Willebrand factor levels were low and platelet aggregation was decreased with different concentrations of Ristocetin®.

No improvement was seen after the tranfusion of cryoprecipitates, and there was no increase in procoagulant Factor-VIII.

Clinical improvement resulted after treatment with corticosteroids, and later, the laboratory abnormalities characteristic of von Willebrand’s disease became normal. The level of procoagulant factor-VIII reached the very high level of 810%.